Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort

BACKGROUND: Interferon-β is an attractive drug for repurposing and use in the treatment of COVID-19, based on its in vitro antiviral activity and the encouraging results from clinical trials. The aim of this study was to analyze the impact of early interferon-β treatment in patients admitted with CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Salto-Alejandre, Sonsoles, Palacios-Baena, Zaira R., Arribas, José Ramón, Berenguer, Juan, Carratalà, Jordi, Jarrín, Inmaculada, Ryan, Pablo, Miguel-Montero, Marta de, Rodríguez-Baño, Jesús, Pachón, Jerónimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Masson SAS. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692085/
https://www.ncbi.nlm.nih.gov/pubmed/34954640
http://dx.doi.org/10.1016/j.biopha.2021.112572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692085/
https://www.ncbi.nlm.nih.gov/pubmed/34954640
http://dx.doi.org/10.1016/j.biopha.2021.112572

Ejemplares similares